Pharmacy practice and the health care system in Saudi Arabia A Al-Jedai, S Qaisi, A Al-Meman The Canadian journal of hospital pharmacy 69 (3), 231, 2016 | 97 | 2016 |
Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study M AlJumah, R Bunyan, H Al Otaibi, G Al Towaijri, A Karim, Y Al Malik, ... BMC neurology 20, 1-7, 2020 | 93 | 2020 |
COVID-19 delta variant: perceptions, worries, and vaccine-booster acceptability among healthcare workers K Alhasan, F Aljamaan, MH Temsah, F Alshahrani, R Bassrawi, ... Healthcare 9 (11), 1566, 2021 | 64 | 2021 |
Hospital pharmacy practice in Saudi Arabia: Drug monitoring and patient education in the Riyadh region MS Alsultan, AY Mayet, F Khurshid, AH Al-Jedai Saudi Pharmaceutical Journal 21 (4), 361-370, 2013 | 64 | 2013 |
Hospital pharmacy practice in Saudi Arabia: Dispensing and administration in the Riyadh region MS Alsultan, F Khurshid, AY Mayet, AH Al-Jedai Saudi Pharmaceutical Journal 20 (4), 307-315, 2012 | 59 | 2012 |
Colistin nephrotoxicity: meta-analysis of randomized controlled trials K Eljaaly, MR Bidell, RG Gandhi, S Alshehri, MA Enani, A Al-Jedai, ... Open forum infectious diseases 8 (2), ofab026, 2021 | 47 | 2021 |
A three-year study of a first-generation chemotherapy-compounding robot Z Nurgat, D Faris, M Mominah, A Vibar, A Al-Jazairi, S Ewing, M Ashour, ... American Journal of Health-System Pharmacy 72 (12), 1036-1045, 2015 | 46 | 2015 |
Hospital pharmacy practice in Saudi Arabia: Prescribing and transcribing in the Riyadh region MS Alsultan, F Khurshid, HJ Salamah, AY Mayet, AH Al-Jedai Saudi Pharmaceutical Journal 20 (3), 203-210, 2012 | 43 | 2012 |
Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation BT Duhart Jr, MR Honaker, MH Shokouh‐Amiri, CA Riely, SR Vera, ... Transplant infectious disease 5 (3), 126-131, 2003 | 40 | 2003 |
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients HA Hakeam, AH Al-Jedai, SM Raza, K Hamawi Ann Transplant 13 (2), 46-53, 2008 | 36 | 2008 |
Clinical pharmacy practice in Saudi Arabia: Historical evolution and future perspective HA Badreldin, S Alosaimy, A Al‐jedai Journal of the American College of Clinical Pharmacy 3 (5), 920-929, 2020 | 35 | 2020 |
Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation AH Al-Jedai, MR Honaker, J Trofe, MF Egidi, LW Gaber, AO Gaber, ... Transplantation 75 (4), 490-494, 2003 | 35 | 2003 |
Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching … A Alamer, AA Alrashed, M Alfaifi, B Alosaimi, F AlHassar, M Almutairi, ... Current medical research and opinion 37 (7), 1085-1097, 2021 | 34 | 2021 |
Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia EA Tawfik, AF Tawfik, AM Alajmi, MY Badr, A Al-Jedai, NH Almozain, ... Saudi Pharmaceutical Journal 30 (1), 28-38, 2022 | 33 | 2022 |
Clinical outcomes for Saudi and Egyptian patients receiving deceased donor liver transplantation in China N Allam, M Al Saghier, Y El Sheikh, M Al Sofayan, H Khalaf, M Al Sebayel, ... American Journal of Transplantation 10 (8), 1834-1841, 2010 | 31 | 2010 |
Potentially inappropriate medications in older patients based on Beers criteria: a cross-sectional study of a family medicine practice in Saudi Arabia A Alturki, T Alaama, Y Alomran, A Al-Jedai, H Almudaiheem, G Watfa BJGP open 4 (1), 2020 | 28 | 2020 |
Cost analysis of kidney transplantation in highly sensitized recipients compared to intermittent maintenance hemodialysis A Al-Jedai, M Alsultan, K Almeshari, K Alshaibani, H Elgamal, D Alkortas, ... Ann Transplant 17 (4), 82-91, 2012 | 28 | 2012 |
Current COVID-19 vaccine candidates: Implications in the Saudi population AATA Raja, A Alshamsan, A Al-Jedai Saudi Pharmaceutical Journal 28 (12), 1743-1748, 2020 | 25 | 2020 |
Pharmacy practice in the Kingdom of Saudi Arabia A Almeman, A Al-jedai Pharmacy practice in developing countries, 171-197, 2016 | 24 | 2016 |
HBsAg clearance in chronic hepatitis B patients with add-on pegylated interferon alfa-2a to ongoing tenofovir treatment: a randomized controlled study H Al Ashgar, MC Peedikayil, M Al Quaiz, F Al Sohaibani, A Al Fadda, ... Saudi Journal of Gastroenterology 23 (3), 190-198, 2017 | 23 | 2017 |